| Literature DB >> 35517287 |
Liqi Wang1, Limin Gong1, Lin Zhu1, Chucai Peng1, Jianling Liao2, Linfu Ke2, Bing Dong1.
Abstract
This study was conducted to evaluate the effects of activated charcoal-herb extractum complex (CHC) on the growth performance, immunological indices, intestinal morphology and microflora in weaning piglets to determine the optimal supplemental dose. A total of 216 weaned piglets (Duroc × Landrace × Large White) with an initial body weight of 8.55 ± 1.18 kg were randomly assigned to six treatment groups; each treatment group had six pens, with six pigs per pen. The study period was 28 d. Pigs were fed a corn-soybean meal-based diet supplemented with 500, 1000, 1500 or 2000 mg kg-1 of CHC over two 14-d periods. Two additional diets containing 0 and 1000 mg kg-1 of montmorillonite were set as the negative and positive controls, respectively. Supplementation with 500 mg kg-1 of CHC significantly increased average daily gain compared with the positive and negative controls during phase I and the entire experimental period (P < 0.05). During phase I, 500 and 1000 mg kg-1 of CHC significantly decreased diarrhea incidence compared with the negative control, and increased serum IGF-1 and serum IgM levels compared with the controls (P < 0.05). CHC at 500 mg kg-1 significantly decreased the diarrhea score during the entire experimental period compared with the negative control (P < 0.05). On day 28, supplementation with 500 and 1000 mg kg-1 of CHC increased serum IgG, IL-1β, and duodenum and jejunum secretory IgA compared with the negative control and decreased duodenum and jejunum MDA levels compared with the controls (P < 0.05). Increased duodenum and jejunum villus height and an increased ratio of villus height to crypt depth were observed compared with the negative control and decreased viable counts of E. coli in the cecum were detected compared with the controls (P < 0.05). Collectively, the optimal dose of CHC was found to be 500 to 1000 mg kg-1 in this study. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35517287 PMCID: PMC9060878 DOI: 10.1039/c8ra10283j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
The composition and analyzed nutrient levels of basal diets (%, as-fed basis)a
| Items | Phase I | Phase II |
|---|---|---|
| Corn | 59.15 | 60.49 |
| Soybean meal (45% crude protein) | 14.31 | 18.08 |
| Soybean oil | 2.80 | 2.60 |
| Fish meal | 2.40 | 2.20 |
| Soy protein concentrate | 10.10 | 4.80 |
| Whey powder (12% crude protein) | 7.32 | 8.29 |
| Dicalcium phosphate | 1.26 | 1.10 |
| Limestone | 0.72 | 0.60 |
| Salt | 0.24 | 0.24 |
|
| 0.51 | 0.50 |
|
| 0.18 | 0.15 |
| Tryptophan | 0.03 | 0.03 |
| Methionine hydroxy analogue | 0.28 | 0.23 |
| Choline chloride (50%) | 0.20 | 0.20 |
| Vitamine-mineral premix | 0.50 | 0.50 |
| Total | 100.00 | 100.00 |
|
| ||
| Digestible energy, Mcal kg−1 | 3.542 | 3.490 |
| Dry matter | 89.05 | 88.43 |
| Crude protein | 20.93 | 20.33 |
| Ash | 4.94 | 4.86 |
| Ether extract | 5.50 | 5.61 |
| Crude fiber | 3.02 | 2.98 |
| Lysine | 1.53 | 1.38 |
| Methionine | 0.56 | 0.53 |
| Methionine + cystine | 0.87 | 0.79 |
| Threonine | 0.98 | 0.89 |
| Calcium | 0.76 | 0.73 |
| Total phosphorus | 0.62 | 0.58 |
Corn was replaced with MMT or CHC in the other treatments.
Provided per kg of diet: vitamin A, 12 000 IU; vitamin D3, 2000 IU; vitamin E, 30 IU; vitamin K3, 2.5 mg; thiamine, 2.5 mg; riboflavin, 4 mg; pyridoxine, 3 mg; vitamin B12, 20 μg; niacin, 40 mg; pantothenic acid, 12.5 mg; folic acid, 0.7 mg; biotin, 0.07 mg; Fe, 100 mg; Cu, 90 mg; Zn, 80 mg; Mn, 30 mg; I, 0.25 mg; Se, 0.15 mg.
All data are analyzed values except for digestible energy.
Fig. 1The physical characteristics of MMT and CHC. (A) The pore development of MMT and CHC as analyzed by high-resolution scanning electron microscopy (SEM). (B) The physical characteristics, including surface area and iodine sorption value, of MMT and CHC.
Effects of graded levels of CHC on growth performance in weaned pigletsa (n = 6)
| Items | MMT, mg kg−1, 1000 | CHC, mg kg−1 | SEM |
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 500 | 1000 | 1500 | 2000 | ANOVA | Linear | Quadratic | |||
|
| ||||||||||
| 0 d, kg | 8.55 | 8.55 | 8.54 | 8.54 | 8.55 | 8.55 | 0.02 | 0.99 | 0.73 | 0.86 |
| 14 d, kg | 13.17b | 13.13b | 13.78a | 13.41ab | 13.07b | 13.02b | 0.17 | 0.04 | 0.10 | 0.06 |
| 28 d, kg | 20.56b | 20.78b | 22.10a | 21.45ab | 20.89b | 20.85b | 0.35 | 0.05 | 0.04 | 0.15 |
|
| ||||||||||
| ADG, kg | 0.33b | 0.33b | 0.37a | 0.35ab | 0.32b | 0.32b | 0.01 | 0.04 | 0.11 | 0.07 |
| ADFI, kg | 0.50 | 0.52 | 0.55 | 0.52 | 0.51 | 0.51 | 0.01 | 0.16 | 0.27 | 0.10 |
|
| 1.54 | 1.60 | 1.49 | 1.51 | 1.60 | 1.60 | 0.03 | 0.12 | 0.15 | 0.28 |
| Diarrhea score | 1.28 | 1.44 | 0.90 | 1.11 | 1.69 | 1.69 | 0.26 | 0.21 | 0.52 | 0.14 |
| Diarrhea incidence% | 5.28ab | 7.14a | 3.17b | 3.77b | 5.60ab | 5.95ab | 0.89 | 0.04 | 0.05 | 0.93 |
|
| ||||||||||
| ADG, kg | 0.53 | 0.55 | 0.59 | 0.57 | 0.56 | 0.56 | 0.02 | 0.14 | 0.10 | 0.56 |
| ADFI, kg | 0.83 | 0.86 | 0.89 | 0.88 | 0.86 | 0.89 | 0.03 | 0.76 | 0.62 | 0.94 |
|
| 1.58 | 1.59 | 1.48 | 1.53 | 1.53 | 1.60 | 0.04 | 0.45 | 0.34 | 0.70 |
| Diarrhea score | 0.89 | 1.17 | 0.44 | 0.61 | 1.14 | 1.08 | 0.21 | 0.10 | 0.18 | 0.37 |
| Diarrhea incidence% | 4.88 | 4.17 | 3.17 | 5.16 | 4.56 | 3.77 | 0.90 | 0.65 | 0.20 | 0.28 |
|
| ||||||||||
| ADG, kg | 0.43b | 0.44b | 0.48a | 0.46ab | 0.44b | 0.44b | 0.01 | <0.05 | 0.04 | 0.13 |
| ADFI, kg | 0.67 | 0.69 | 0.72 | 0.70 | 0.69 | 0.70 | 0.02 | 0.56 | 0.39 | 0.43 |
|
| 1.57 | 1.59 | 1.48 | 1.52 | 1.55 | 1.59 | 0.03 | 0.16 | 0.14 | 0.49 |
| Diarrhea score | 1.08abc | 1.31ab | 0.65c | 0.86bc | 1.42a | 1.39a | 0.16 | 0.01 | 0.18 | 0.09 |
| Diarrhea incidence% | 5.08 | 5.66 | 3.18 | 4.47 | 5.08 | 4.86 | 0.58 | 0.10 | 0.03 | 0.44 |
a,b,cMeans within the same row without common superscripts differ significantly (P < 0.05).
SEM standard error of the means, BW body weight, ADG average daily gain, ADFI average daily feed intake, F : G feed to gain ratio.
Effects of graded levels of CHC on serum immunological parameters in weaned pigletsa (n = 6)
| Items | MMT, mg kg−1, 1000 | CHC, mg kg−1 | SEM |
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 500 | 1000 | 1500 | 2000 | ANOVA | Linear | Quadratic | ||||
|
| |||||||||||
| IgM, g L−1 | 0.70 | 0.76 | 0.94 | 0.84 | 0.71 | 0.88 | 0.07 | 0.25 | 0.14 | 0.37 | |
| IgA, g L−1 | 1.08 | 1.06 | 0.94 | 0.91 | 1.04 | 0.83 | 0.13 | 0.75 | 0.54 | 0.89 | |
| IgG, g L−1 | 9.84 | 8.34 | 9.53 | 10.13 | 9.18 | 9.06 | 0.36 | 0.09 | 0.28 | 0.30 | |
| IL-1β, pg mL−1 | 51.77 | 55.50 | 57.93 | 54.30 | 54.51 | 54.94 | 1.17 | 0.13 | 0.49 | 0.09 | |
| IFN-γ, pg mL−1 | 68.49 | 71.05 | 76.53 | 70.80 | 75.17 | 75.83 | 2.80 | 0.26 | 0.06 | 0.85 | |
|
| |||||||||||
| IgM, g L−1 | 0.85c | 0.77c | 1.54ab | 1.76a | 1.13bc | 1.15bc | 0.16 | <0.01 | 0.09 | 0.67 | |
| IgA, g L−1 | 1.42 | 1.14 | 1.05 | 1.17 | 1.37 | 1.07 | 0.14 | 0.34 | 0.48 | 0.21 | |
| IgG, g L−1 | 8.63 | 9.60 | 10.23 | 11.10 | 9.26 | 9.45 | 0.73 | 0.26 | 0.88 | 0.85 | |
| IL-1β, pg mL−1 | 48.14 | 53.45 | 49.15 | 57.57 | 58.71 | 61.32 | 5.10 | 0.38 | 0.77 | 0.13 | |
| IFN-γ, pg mL−1 | 58.61 | 66.17 | 63.42 | 60.12 | 59.24 | 61.97 | 2.90 | 0.45 | 0.71 | 0.12 | |
|
| |||||||||||
| IgM, g L−1 | 0.78 | 1.04 | 1.39 | 1.44 | 0.94 | 1.06 | 0.19 | 0.15 | 0.66 | 0.56 | |
| IgA, g L−1 | 1.29 | 1.27 | 1.12 | 1.19 | 1.46 | 1.05 | 0.12 | 0.23 | 0.18 | 0.34 | |
| IgG, g L−1 | 10.54a | 8.66b | 10.85a | 10.70a | 9.67ab | 9.96ab | 0.48 | 0.03 | 0.02 | 0.58 | |
| IL-1β, pg mL−1 | 75.60ab | 65.81b | 92.96a | 91.37a | 66.81b | 60.27b | 7.31 | 0.01 | 0.37 | 0.28 | |
| IFN-γ, pg mL−1 | 62.28 | 62.62 | 62.54 | 61.05 | 59.56 | 59.69 | 2.34 | 0.87 | 0.82 | 0.19 | |
a,b,cMeans within the same row without common superscripts differ significantly (P < 0.05).
IgM immune globulin M, IgA immune globulin A, IgG immune globulin G, IL-1β interleukin-1β, IFN-γ interferon-γ.
Fig. 2Effects of graded levels of CHC on the intestinal mucosa SIgA and MDA levels in weaned piglets (n = 6). *Represents a significant difference between groups (P < 0.05), **represents a significant difference between groups (P < 0.01). CHC, 500, 1000, 1500 and 2000 indicate the amount of CHC added as a dietary supplement, i.e., 500, 1000, 1500 and 2000 mg kg−1 of CHC per group, respectively.
Effects of graded levels of CHC on intestinal morphology in weaned pigletsa (n = 6)
| Items | MMT, mg kg−1, 1000 | CHC, mg kg−1 | SEM |
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 500 | 1000 | 1500 | 2000 | ANOVA | Linear | Quadratic | ||||
|
| |||||||||||
| Villous height, μm | 347.20b | 338.40b | 422.60a | 432.40a | 335.40b | 300.85b | 22.29 | <0.01 | 0.41 | 0.32 | |
| Crypt depth, μm | 272.20 | 277.80 | 284.60 | 283.60 | 254.00 | 261.60 | 19.84 | 0.85 | 0.90 | 0.39 | |
|
| 1.28bc | 1.22c | 1.49a | 1.52a | 1.34abc | 1.31abc | 0.07 | 0.03 | 0.16 | 0.78 | |
|
| |||||||||||
| Villous height, μm | 345.40ab | 272.40b | 366.20a | 398.75a | 350.00a | 344.40ab | 23.76 | 0.04 | 0.08 | 0.06 | |
| Crypt depth, μm | 247.60 | 259.40 | 269.20 | 267.50 | 295.60 | 286.20 | 17.14 | 0.42 | 0.49 | 0.15 | |
|
| 1.40ab | 1.05c | 1.37ab | 1.53a | 1.19bc | 1.16bc | 0.07 | < 0.01 | 0.28 | 0.43 | |
|
| |||||||||||
| Villous height, μm | 339.50 | 328.80 | 362.40 | 344.00 | 266.00 | 305.00 | 26.62 | 0.11 | 0.72 | 0.06 | |
| Crypt depth, μm | 244.50 | 248.60 | 255.00 | 258.20 | 210.40 | 231.40 | 183.98 | 0.11 | 0.73 | 0.06 | |
|
| 1.40 | 1.33 | 1.44 | 1.35 | 1.28 | 1.35 | 0.13 | 0.96 | 0.59 | 0.59 | |
a,b,cMeans within the same row without common superscripts differ significantly (P < 0.05).
Effects of graded levels of CHC on the intestinal microflora in weaned pigletsa (n = 6)
| Items | MMT, mg kg−1, 1000 | CHC, mg kg−1 | SEM |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 500 | 1000 | 1500 | 2000 | ANOVA | Linear | Quadratic | |||||||
|
| ||||||||||||||
| Total microbial | 7.73 | 7.24 | 7.62 | 8.24 | 7.86 | 7.57 | 0.31 | 0.34 | 0.92 | 0.11 | ||||
|
| 6.46 | 5.98 | 6.60 | 7.15 | 6.51 | 6.22 | 0.43 | 0.53 | 0.84 | 0.45 | ||||
|
| 1.43 | 1.71 | 1.33 | 0.51 | 2.30 | 2.50 | 0.75 | 0.48 | 0.61 | 0.60 | ||||
|
| ||||||||||||||
| Total microbial | 7.62 | 7.43 | 7.35 | 7.28 | 7.83 | 7.36 | 0.24 | 0.61 | 0.91 | 0.43 | ||||
|
| 6.16 | 6.12 | 6.71 | 6.68 | 6.30 | 6.22 | 0.30 | 0.59 | 0.50 | 0.90 | ||||
|
| 3.70a | 4.00a | 2.52b | 3.01b | 3.38ab | 3.19ab | 0.31 | 0.04 | 0.01 | 0.99 | ||||
|
| ||||||||||||||
| Total microbial | 8.25 | 8.22 | 8.04 | 8.14 | 8.21 | 8.08 | 0.21 | 0.98 | 0.56 | 0.88 | ||||
|
| 7.91 | 7.55 | 7.51 | 7.41 | 7.71 | 7.26 | 0.34 | 0.80 | 0.85 | 0.99 | ||||
|
| 3.57 | 3.41 | 2.83 | 3.28 | 3.44 | 3.49 | 0.40 | 0.83 | 0.49 | 0.46 | ||||
a,b,cMeans within the same row without common superscripts differ significantly (P < 0.05).
Effects of graded levels of CHC on serum hormones in weaned pigletsa (n = 6)
| Items | MMT, mg kg−1, 1000 | CHC, mg kg−1 | SEM |
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 500 | 1000 | 1500 | 2000 | ANOVA | Linear | Quadratic | ||||
|
| |||||||||||
| GH, ng mL−1 | 6.95 | 7.50 | 7.32 | 7.21 | 7.52 | 7.75 | 0.41 | 0.81 | 0.89 | 0.82 | |
| INS, μIU mL−1 | 11.72 | 11.98 | 11.89 | 11.75 | 11.40 | 10.20 | 1.18 | 0.90 | 0.63 | 0.49 | |
| IGF-1, ng mL | 156.01b | 141.38c | 173.37a | 170.46a | 155.42b | 152.57b | 2.87 | <0.01 | 0.14 | 0.48 | |
| COR, μg dL−1 | 5.44 | 5.04 | 5.40 | 5.50 | 5.60 | 5.57 | 0.92 | 0.99 | 0.77 | 0.67 | |
|
| |||||||||||
| GH, ng mL−1 | 7.12 | 7.56 | 7.28 | 7.56 | 7.59 | 7.76 | 0.44 | 0.92 | 0.82 | 0.65 | |
| INS, μIU mL−1 | 13.19 | 12.17 | 12.31 | 11.90 | 12.25 | 12.12 | 1.21 | 0.98 | 0.89 | 0.91 | |
| IGF-1, ng mL | 154.38 | 152.35 | 166.13 | 164.72 | 149.34 | 149.78 | 5.39 | 0.13 | 0.86 | 0.17 | |
| COR, μg dL−1 | 7.21 | 6.95 | 6.80 | 6.63 | 6.56 | 6.84 | 0.17 | 0.99 | 0.98 | 0.84 | |
a,b,cMeans within the same row without common superscripts differ significantly (P < 0.05).
GH growth hormone, INS insulin, IGF-1 insulin-like growth factor-I, COR cortisol.